DelMar Pharmaceuticals Announces Completion of First Site Initiation Visit for STAR-3 Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM Jul 19, 2017
Naturally Splendid Enterprises to Acquire 100% of Privately Owned Innovative Natural Food Company – Video News Alert on Investmentpitch.com Jul 15, 2017 Life Science
RedHill Biopharma Announces Expected Timeline for DSMB meeting and Provides Update on Enrollment in the RHB-104 Phase III Study for Crohn’s Disease Jul 13, 2017 Life Science
Naturally Splendid Enters into Letter of Intent to Acquire Innovative Natural Food Company and Announces Private Placement Financing Jul 13, 2017 Life Science
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman Jul 12, 2017 Life Science
Resverlogix and Hepalink Start Taiwan/China Trial of CVD/Diabetes Treatment Jul 11, 2017 Life Science
Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial Jul 11, 2017 Life Science
Google Invests Undisclosed Sum Into Boston’s Decibel And Its Hearing Loss R&D Program Jul 6, 2017 Life Science
Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) is a Technology Disruptor for Edible Cannabinoids Jul 6, 2017 Life Science
BeiGene Initiates Pivotal Trial of PD-1 Antibody BGB-A317 in China in Patients with Urothelial Cancer Jul 6, 2017 Life Science
DelMar Pharmaceuticals Joins National Brain Tumor Society’s Research Roundtable Jun 30, 2017 Life Science
